Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Colorectal and General Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.
Department of Colorectal and General Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.
Cancer Treat Rev. 2024 Jul;128:102753. doi: 10.1016/j.ctrv.2024.102753. Epub 2024 May 12.
Local resection (LR) methods for rectal cancer are generally considered in the palliative setting or for patients deemed a high anaesthetic risk. This systematic review and meta-analysis aimed to compare oncological outcomes of LR and radical resection (RR) for early rectal cancer in the context of staging and surveillance assessment.
A literature search of MEDLINE, Embase and Emcare databases was performed for studies that reported data on clinical outcomes for both LR and RR for early rectal cancer from January 1995 to April 2023. Meta-analysis was performed using random-effect models and between-study heterogeneity was assessed. The quality of assessment was assessed using the Newcastle-Ottawa Scale for observational studies and the Cochrane Risk of Bias 2.0 tool for randomised controlled trials.
Twenty studies with 12,022 patients were included: 6,476 patients had LR and 5,546 patients underwent RR. RR led to an improvement in 5-year overall survival (OR 1.84; 95 % CI 1.54-2.20; p < 0.0001; I 20 %) and local recurrence (OR 3.06; 95 % CI 2.02-4.64; p < 0.0001; I 39 %) when compared to LR. However, when staging and surveillance methods were clearly adopted in LR cases, there was an improvement in R0 rates (96.7 % vs 85.6 %), 5-year disease-free survival (93.0 % vs 77.9 %) and overall survival (81.6 % vs 79.0 %) compared to when staging and surveillance was not reported/performed.
LR may be appropriate for selected patients without poor prognostic factors in early rectal cancer. This study also highlights that there is currently no single standardised staging or surveillance approach being adopted in the management of early rectal cancer. A more specified and standardised preoperative staging for patient selection as well as clinical and image-based surveillance protocols is needed.
局部切除术(LR)通常被认为是直肠癌的姑息性治疗方法,或者适用于被认为存在高麻醉风险的患者。本系统评价和荟萃分析旨在比较 LR 和根治性切除术(RR)治疗早期直肠癌的肿瘤学结局,其背景为分期和监测评估。
从 1995 年 1 月至 2023 年 4 月,对 MEDLINE、Embase 和 Emcare 数据库进行文献检索,以检索报告早期直肠癌 LR 和 RR 临床结局数据的研究。使用随机效应模型进行荟萃分析,并评估研究间异质性。使用纽卡斯尔-渥太华量表评估观察性研究的质量,使用 Cochrane 偏倚风险 2.0 工具评估随机对照试验的质量。
纳入 20 项研究,共 12022 例患者:6476 例患者接受 LR,5546 例患者接受 RR。与 LR 相比,RR 可提高 5 年总生存率(OR 1.84;95%CI 1.54-2.20;p<0.0001;I 20%)和局部复发率(OR 3.06;95%CI 2.02-4.64;p<0.0001;I 39%)。然而,当明确采用 LR 时,R0 率(96.7%vs85.6%)、5 年无病生存率(93.0%vs77.9%)和总生存率(81.6%vs79.0%)均得到改善。
LR 可能适用于早期直肠癌中无不良预后因素的选定患者。本研究还强调,目前在早期直肠癌的管理中没有采用单一的标准化分期或监测方法。需要为患者选择制定更具体和标准化的术前分期以及临床和基于影像的监测方案。